SCHEMBL967959

SCHEMBL967959

O=C(CN1CCc2c([nH]c3ccc(Br)cc23)C1)N1CCN(C2CCC2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 4/20 0.54
ALDH1A1 P00352 4/20 0.54
MAPT P10636 4/20 0.54
MAPK1 P28482 1/20 0.54
PARP1 P09874 4/20 0.52
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
BAZ2B Q9UIF8 2/20 0.47
KMT2A Q03164 3/20 0.47
HTT P42858 2/20 0.47
TP53 P04637 2/20 0.47
TSHR P16473 2/20 0.47
CYP1A2 P05177 1/20 0.47
POLB P06746 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
ALOX15 P16050 1/20 0.47
CYP2C19 P33261 1/20 0.47
CTNNB1 P35222 1/20 0.47
SIRT1 Q96EB6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13985808 0.89 PARP1 (0.52) USP2ALDH1A1MAPTMAPK1PARP1
SCHEMBL970353 0.89 PARP1 (0.52) USP2ALDH1A1MAPTPARP1KDM4E
SCHEMBL967791 0.89 NPC1 (0.58) USP2ALDH1A1MAPTPARP1KDM4E
SCHEMBL970324 0.86 ALDH1A1 (0.64) ALDH1A1MAPTPARP1KDM4EHPGD
SCHEMBL967938 0.86 HDAC1 (0.54) USP2ALDH1A1PARP1KDM4EHPGD
SCHEMBL968649 0.86 PARP1 (0.50) USP2ALDH1A1MAPTMAPK1PARP1
SCHEMBL969089 0.85 PARP1 (0.65) ALDH1A1MAPTPARP1KDM4EHPGD
SCHEMBL968434 0.84 ALDH1A1 (0.64) ALDH1A1MAPTPARP1KDM4EHPGD
SCHEMBL968632 0.84 PARP1 (0.48) USP2ALDH1A1MAPTMAPK1PARP1
SCHEMBL967118 0.83 ALDH1A1 (0.63) ALDH1A1MAPTPARP1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US claimed
EP-2162451-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES Neurogen Corporation (US) 2010-03-17 EP claimed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO claimed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
EP-2162451-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES Neurogen Corporation (US) 2010-03-17 EP disclosed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO disclosed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 USP2 3093/4885ALDH1A1 812/4885MAPT 3870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.